Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B

References

• Chambers HF, Deleo FR. Waves of resistance: staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629–41. PMID:19680247. doi:10.1038/nrmicro2200.
   PubMed Web of Science ®Google Scholar
• Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev. 2000;13:16–34. PMID:10627489. doi:10.1128/cmr.13.1.16-34.2000.
   PubMed Web of Science ®Google Scholar
• Li H, Llera A, Tsuchiya D, Leder L, Ysern X, Schlievert PM, Karjalainen K, Mariuzza RA. Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity. 1998;9:807–16. PMID:9881971. doi:10.1016/s1074-7613(00)80646-9.
   PubMed Web of Science ®Google Scholar
• Krakauer T. Staphylococcal superantigens: pyrogenic toxins induce toxic shock. Toxins (Basel). 2019;11:178. PMID:30909619. doi:10.3390/toxins11030178.
   PubMed Web of Science ®Google Scholar
• Hudson Reichenberg LC, Garg R, Fernalld R, Bost KL, Piller KJ. Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B. Toxicon. 2017;133:82–90. PMID:28478060. doi:10.1016/j.toxicon.2017.05.005.
   PubMed Web of Science ®Google Scholar
• Rajagopalan G, Sen MM, Singh M, Murali NS, Nath KA, Iijima K. Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock. 2006;25:647–56. PMID:16721274. doi:10.1097/01.shk.0000209565.92445.7d.
   PubMed Web of Science ®Google Scholar
• Krakauer T, Buckley MJ, Fisher D. Proinflammatory mediators of toxic shock and their correlation to lethality. Mediators Inflamm. 2010;2010:517594. PMID:20634937. doi:10.1155/2010/517594.
   PubMed Web of Science ®Google Scholar
• Krakauer T, Stiles BG. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence. 2013;4:759–73. PMID:23959032. doi:10.4161/viru.23905.
   PubMed Web of Science ®Google Scholar
• Raj HD, Bergdoll MS. Effect of enterotoxin B on human volunteers. J Bacteriol. 1969;98:833–34. PMID:4977485. doi:10.1128/JB.98.2.833-834.1969.
   PubMed Web of Science ®Google Scholar
• McKallip RJ, Fisher M, Do Y, Szakal AK, Gunthert U, Nagarkatti PS, Nagarkatti M. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. J Biol Chem. 2003;278:43818–30. PMID:12904302. doi:10.1074/jbc.M304467200.
   PubMed Web of Science ®Google Scholar
• Ahanotu E, Alvelo-Ceron D, Ravita T. Staphylococcal enterotoxin B as a BIOLOGICAL WEAPon: recognition, management, and surveillance of staphylococcal enterotoxin. Appl Biosaf. 2006;11:120–26. doi:10.1177/153567600601100303.
   Google Scholar
• Balali-Mood M, Moshiri M, Etemad L. Medical aspects of bio-terrorism. Toxicon. 2013;69:131–42. PMID:23339855. doi:10.1016/j.toxicon.2013.01.005.
   PubMed Web of Science ®Google Scholar
• Lindsay CD, Griffiths GD. Addressing bioterrorism concerns: options for investigating the mechanism of action of Staphylococcus aureus enterotoxin B. Hum Exp Toxicol. 2013;32:606–19. PMID:23023027. doi:10.1177/0960327112458941.
   PubMed Web of Science ®Google Scholar
• Henghold WB 2nd., Other biologic toxin bioweapons: ricin, staphylococcal enterotoxin B, and trichothecene mycotoxins. Dermatol Clin. 2004;22:257–62. PMID:15207307. DOI:10.1016/j.det.2004.03.004.
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Staphylococcus aureus toxin antibodies: good companions of antibiotics and vaccines. Virulence. 2017;8:1037–42. PMID:28267417. DOI:10.1080/21505594.2017.1295205.
   PubMed Web of Science ®Google Scholar
• Song Z. Sorting of MRSA human monoclonal antibodies based on single B cell technology. Immunol J. 2019;35:254–61. doi:10.13431/j.cnki.immunol.j.20190041.
   Google Scholar
• Liao HX, Levesque MC, Nagel A, Dixon A, Zhang R, Walter E, Parks R, Whitesides J, Marshall DJ, Hwang -K-K. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods. 2009;158:171–79. PMID:19428587. doi:10.1016/j.jviromet.2009.02.014.
   PubMed Web of Science ®Google Scholar
• Inskeep TK, Stahl C, Odle J, Oakes J, Hudson L, Bost KL, Piller KJ. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model. Clin Vaccine Immunol. 2010;17:1163–69. PMID:20554806. doi:10.1128/cvi.00078-10.
   PubMedGoogle Scholar
• Pinchuk IV, Beswick EJ, Reyes VE. Staphylococcal enterotoxins. Toxins (Basel). 2010;2:2177–97. PMID:22069679. doi:10.3390/toxins2082177.
   PubMed Web of Science ®Google Scholar
• Baudet V, Hurez V, Lapeyre C, Kaveri SV, Kazatchkine MD. Intravenous immunoglobulin (IVIg) modulates the expansion of V beta 3+ and V beta 17+ T cells induced by staphylococcal enterotoxin B superantigen in vitro. Scand J Immunol. 1996;43:277–82. PMID:8602461. doi:10.1046/j.1365-3083.1996.d01-36.x.
   PubMed Web of Science ®Google Scholar
• Darenberg J, Soderquist B, Normark BH, Norrby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis. 2004;38:836–42. PMID:14999628. doi:10.1086/381979.
   PubMed Web of Science ®Google Scholar
• Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol. 2001;108:S107–10. PMID:11586276. doi:10.1067/mai.2001.117820.
   PubMed Web of Science ®Google Scholar
• LeClaire RD, Hunt RE, Bavari S, Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect Immun. 2002;70:2278–81. PMID:11953360. DOI:10.1128/iai.70.5.2278-2281.2002.
   PubMed Web of Science ®Google Scholar
• Johnson HM, Bukovic JA, Kauffman PE. Antigenic cross-reactivity of staphylococcal enterotoxins. Infect Immun. 1972;5:645–47. PMID:4674001. doi:10.1128/iai.5.5.645-647.1972.
   PubMed Web of Science ®Google Scholar
• Pang LT, Kum WW, Chow AW. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody. Infect Immun. 2000;68:3261–68. PMID:10816471. doi:10.1128/iai.68.6.3261-3268.2000.
   PubMed Web of Science ®Google Scholar
• Rodstrom KEJ, Regenthal P, Bahl C, Ford A, Baker D, Lindkvist-Petersson K. Two common structural motifs for TCR recognition by staphylococcal enterotoxins. Sci Rep. 2016;6:25796. PMID:27180909. doi:10.1038/srep25796.
   PubMed Web of Science ®Google Scholar
• Papageorgiou AC, Tranter HS, Acharya KR. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J Mol Biol. 1998;277:61–79. PMID:9514739. doi:10.1006/jmbi.1997.1577.
   PubMed Web of Science ®Google Scholar
• Holeckova B, Holoda E, Fotta M, Kalinacova V, Gondol J, Grolmus J. Occurrence of enterotoxigenic Staphylococcus aureus in food. Ann Agric Environ Med. 2002;9:179–82. PMID:12498587.
   PubMed Web of Science ®Google Scholar
• Spaulding AR, Salgado-Pabon W, Kohler PL, Horswill AR, Leung DY, Schlievert PM. Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev. 2013;26:422–47. PMID:23824366. doi:10.1128/cmr.00104-12.
   PubMed Web of Science ®Google Scholar
• Mollick JA, Chintagumpala M, Cook RG, Rich RR. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol. 1991;146:463–68. PMID:1987273.
   PubMed Web of Science ®Google Scholar
• Nagaki M, Muto Y, Ohnishi H, Yasuda S, Sano K, Naito T, Maeda T, Yamada T, Moriwaki H. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology. 1994;106:450–58. PMID:8299910. doi:10.1016/0016-5085(94)90604-1.
   PubMed Web of Science ®Google Scholar
• Chen JY, Qiao Y, Komisar JL, Baze WB, Hsu IC, Tseng J. Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun. 1994;62:4626–31. PMID:7927730. doi:10.1128/IAI.62.10.4626-4631.1994.
   PubMed Web of Science ®Google Scholar
• Sarawar SR, Blackman MA, Doherty PC. Superantigen shock in mice with an inapparent viral infection. J Infect Dis. 1994;170:1189–94. PMID:7963712. doi:10.1093/infdis/170.5.1189.
   PubMed Web of Science ®Google Scholar
• Roy CJ, Warfield KL, Welcher BC, Gonzales RF, Larsen T, Hanson J, David CS, Krakauer T, Bavari S. Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun. 2005;73:2452–60. PMID:15784591. doi:10.1128/iai.73.4.2452-2460.2005.
   PubMed Web of Science ®Google Scholar
• Huzella LM, Buckley MJ, Alves DA, Stiles BG, Krakauer T. Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: a new mouse model. Res Vet Sci. 2009;86:241–47. PMID:18793785. doi:10.1016/j.rvsc.2008.07.020.
   PubMed Web of Science ®Google Scholar
• Dutta K, Varshney AK, Franklin MC, Goger M, Wang X, Fries BC. Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies. J Biol Chem. 2015;290:6715–30. PMID:25572397. doi:10.1074/jbc.M114.630715.
   PubMed Web of Science ®Google Scholar
• Chen G, Karauzum H, Long H, Carranza D, Holtsberg FW, Howell KA, Abaandou L, Zhang B, Jarvik N, Ye W. Potent neutralization of staphylococcal enterotoxin B in vivo by antibodies that block binding to the T-cell receptor. J Mol Biol. 2019;431:4354–67. PMID:30928493. doi:10.1016/j.jmb.2019.03.017.
   PubMed Web of Science ®Google Scholar
• Karau MJ, Tilahun ME, Krogman A, Osborne BA, Goldsby RA, David CS, Mandrekar JN, Patel R, Rajagopalan G. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus. Virulence. 2017;8(7):1148–59. PMID:27925510. doi:10.1080/21505594.2016.1267894.
   PubMed Web of Science ®Google Scholar
• Karauzum H, Chen G, Abaandou L, Mahmoudieh M, Boroun AR, Shulenin S, Devi VS, Stavale E, Warfield KL, Zeitlin L. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome. J Biol Chem. 2012;287:25203–15. PMID:22645125. doi:10.1074/jbc.M112.364075.
   PubMed Web of Science ®Google Scholar
• Larkin EA, Stiles BG, Ulrich RG. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B. PLoS One. 2010;5:e13253. PMID:20949003. doi:10.1371/journal.pone.0013253.
   PubMed Web of Science ®Google Scholar
• Varshney AK, Wang X, Aguilar JL, Scharff MD, Fries BC. Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice. mBio. 2014;5:e01007–14. PMID:24917594. doi:10.1128/mBio.01007-14.
   PubMed Web of Science ®Google Scholar
• Varshney AK, Wang X, Scharff MD, MacIntyre J, Zollner RS, Kovalenko OV, Martinez LR, Byrne FR, Fries BC. Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections. J Infect Dis. 2013;208:2058–66. PMID:23922375. doi:10.1093/infdis/jit421.
   PubMed Web of Science ®Google Scholar
• Varshney AK, Wang X, Cook E, Dutta K, Scharff MD, Goger MJ, Fries BC. Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock. J Biol Chem. 2011;286:9737–47. PMID:21233204. doi:10.1074/jbc.M110.212407.
   PubMed Web of Science ®Google Scholar
• Tilahun ME, Kwan A, Natarajan K, Quinn M, Tilahun AY, Xie C, Margulies DH, Osborne BA, Goldsby RA, Rajagopalan G. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PLoS One. 2011;6:e27203. PMID:22102880. doi:10.1371/journal.pone.0027203.
   PubMed Web of Science ®Google Scholar
• Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov. 2010;9:767–74. PMID:20811384. doi:10.1038/nrd3229.
   PubMed Web of Science ®Google Scholar
• Guthmiller JJ, Dugan HL, Neu KE, Lan LY, Wilson PC. An efficient method to generate monoclonal antibodies from human B cells. Methods Mol Biol. 2019;1904:109–45. PMID:30539468. doi:10.1007/978-1-4939-8958-4_5.
   PubMedGoogle Scholar
• Tiller T. Single B cell antibody technologies. N Biotechnol. 2011;28:453–57. PMID:21473940. doi:10.1016/j.nbt.2011.03.014.
   PubMed Web of Science ®Google Scholar
• Lehar SM, Pillow T, Xu M, Staben L, Kajihara KK, Vandlen R, DePalatis L, Raab H, Hazenbos WL, Hiroshi Morisaki J, et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature. 2015;527:323–28. PMID:26536114. doi:10.1038/nature16057.
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Tan MW. Antibody-antibiotic conjugates: a novel therapeutic platform against bacterial infections. Trends Mol Med. 2017;23:135–49. PMID:28126271. doi:10.1016/j.molmed.2016.12.008.
   PubMed Web of Science ®Google Scholar
• Tkaczyk C, Hamilton MM, Sadowska A, Shi Y, Chang CS, Chowdhury P, Buonapane R, Xiao X, Warrener P, Mediavilla J, et al. Targeting alpha toxin and ClfA with a multimechanistic monoclonal-antibody-based approach for prophylaxis of serious staphylococcus aureus disease. mBio. 2016;7. PMID:27353753. doi:10.1128/mBio.00528-16.
   PubMed Web of Science ®Google Scholar